In addition, Wu et al. (Wu et al., 2012) demonstrated that Acrp30 effectively reduced leptin-induced STAT3 phosphorylation by stimulating the MAPK pathway in aggressive SPEC-2 endometrial cancer cells. Here, ADIPOQ is linked to endometrial cancer.